Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib

NCT03727477 · clinicaltrials.gov ↗

COMPLETED

Status

291

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer Metastatic
ALK Gene Rearrangement Positive
ROS-1 Gene Rearrangement Positive

Sponsor

Intergroupe Francophone de Cancerologie Thoracique

Collaborators

[object Object]